Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 51655-309

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 51655-309). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 309 52 Rev A 03 23)

Label for Rosuvastatin Tablets USP 20 mg, film-coated oral tablets packaged in a container of 30 tablets. The label includes storage instructions, dosage note, and manufacturer details, identifying Northwind Pharmaceuticals Inc. as the repackager. The label also shows the NDC 51655-309-52 and includes barcodes and lot/expiry information.*

FDA Label Image

Figure1 (Figure1)

A Kaplan-Meier cumulative incidence plot comparing Rosuvastatin calcium (20 mg) labeled as Rsuva and placebo over a 5-year period. The y-axis shows cumulative incidence percentage and the x-axis shows years. Numbers at risk decrease over time for both groups. The figure includes a hazard ratio (HR 0.56, 95% CI 0.46-0.69) and a statistically significant p-value (P<0.001).*

FDA Label Image

Figure2 (Figure2)

A data table presenting the number of events for various cardiovascular end points comparing Rosuvastatin calcium 20 mg with placebo, including hazard ratios with 95% confidence intervals and P values. End points listed include primary end point (MCE), cardiovascular death, nonfatal stroke, nonfatal MI, hospitalized unstable angina, and arterial revascularization, accompanied by a hazard ratio forest plot.*

FDA Label Image

Figure3 (Figure3)

A box plot chart comparing the percent change from baseline in LDL-C levels across different doses of four statin drugs: Rosuvastatin (10, 20, 40 mg), Atorvastatin (10, 20, 40, 80 mg), Simvastatin (10, 20, 40, 80 mg), and Pravastatin (10, 20, 40 mg). The y-axis shows percent change with values ranging from 0 to -75, illustrating the LDL-C lowering effect of each dosage.*

FDA Label Image

Logo (Logo)

FDA Label Image

Logo1 (Logo1)

FDA Label Image

Structure (Structure)

Chemical structure of Rosuvastatin calcium, depicting the molecular arrangement with calcium ions (Ca2+) indicated as part of the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.